Versant Ventures
Biotech Investor · 2 portfolio companies
Portfolio
2
Combined Value
$1.5B
Focus Areas
3
Top Stage
Phase 1/2
Investment Focus
Portfolio Companies
| Company | Valuation |
|---|---|
| Bicara Therapeutics | $1.2B |
| LENZ Therapeutics | $327.9M |
Biotech Investor · 2 portfolio companies
| Company | Valuation |
|---|---|
| Bicara Therapeutics | $1.2B |
| LENZ Therapeutics | $327.9M |